Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Source: SeekingAlpha
2026-06-04 13:46:52 ET
More on Amarin
- Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
- Amarin expects $70M in operating expense savings by June 30, 2026 while targeting positive 2026 cash flow
- Amarin GAAP EPS of -$0.03 misses by $0.04, revenue of $45.1M beats by $1.33M
- Seeking Alpha’s Quant Rating on Amarin
- Historical earnings data for Amarin
Read the full article on Seeking Alpha
For further details see:
Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Hikma Pharmaceuticals Plc
NASDAQ: HKMPF
HKMPF Trading
0.0% G/L:
$19.29 Last:
200 Volume:
$19.29 Open:
